Patents by Inventor Kit Lau

Kit Lau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11028445
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: June 8, 2021
    Assignee: Celera Corporation
    Inventors: Kit Lau, Alice Wang
  • Publication number: 20190136326
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 9, 2019
    Inventors: Kit LAU, Alice WANG
  • Publication number: 20160289766
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Application
    Filed: February 3, 2016
    Publication date: October 6, 2016
    Inventors: Kit LAU, Alice WANG
  • Publication number: 20140179548
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Application
    Filed: November 19, 2013
    Publication date: June 26, 2014
    Applicant: CELERA CORPORATION
    Inventors: Kit LAU, Alice WANG
  • Patent number: 8614058
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: December 24, 2013
    Assignee: Celera Corporation
    Inventors: Kit Lau, Alice Wang
  • Publication number: 20100323921
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Application
    Filed: December 15, 2009
    Publication date: December 23, 2010
    Applicant: CELERA CORPORATION
    Inventors: Kit LAU, Alice WANG
  • Patent number: 7695915
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: April 13, 2010
    Assignee: Celera Corporation
    Inventors: Kit Lau, Alice Wang
  • Publication number: 20080206769
    Abstract: The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
    Type: Application
    Filed: January 31, 2008
    Publication date: August 28, 2008
    Applicant: APPLERA CORPORATION
    Inventors: Kit Lau, Alice Wang
  • Publication number: 20080081536
    Abstract: Playsets are disclosed. The playsets may include a support surface and a pop-up structure. The pop-up structure may be adapted to be selectively transitioned between a stowed configuration and a deployed configuration. In the stowed configuration the pop-up structure may be collapsed and may extend along the support surface. In the deployed configuration the pop-up structure may stand substantially transverse to the support surface.
    Type: Application
    Filed: June 11, 2007
    Publication date: April 3, 2008
    Inventors: Julian Payne, Kwun Mo, Chung Chcung, Kit Lau